Obesity/Metabolic Syndrome Impact of Abdominal Obesity on Incidence of Adverse Metabolic Effects Associated With Antihypertensive Medications

نویسندگان

  • Rhonda M. Cooper-DeHoff
  • Sheron Wen
  • Amber L. Beitelshees
  • Issam Zineh
  • John G. Gums
  • Stephen T. Turner
  • Yan Gong
  • Karen Hall
  • Vishal Parekh
  • Arlene B. Chapman
  • Eric Boerwinkle
  • Julie A. Johnson
چکیده

We assessed adverse metabolic effects of atenolol and hydrochlorothiazide among hypertensive patients with and without abdominal obesity using data from a randomized, open-label study of hypertensive patients without evidence of cardiovascular disease or diabetes mellitus. Intervention included randomization to 25 mg of hydrochlorothiazide or 100 mg of atenolol monotherapy followed by their combination. Fasting glucose, insulin, triglycerides, high-density lipoprotein cholesterol, and uric acid levels were measured at baseline and after monotherapy and combination therapy. Outcomes included new occurrence of and predictors for new cases of glucose 100 mg/dL (impaired fasting glucose), triglyceride 150 mg/dL, high-density lipoprotein 40 mg/dL for men or 50 mg/dL for women, or new-onset diabetes mellitus according to the presence or absence of abdominal obesity. Abdominal obesity was present in 167 (58%) of 395 patients. Regardless of strategy, in those with abdominal obesity, 20% had impaired fasting glucose at baseline compared with 40% at the end of study (P 0.0001). Proportion with triglycerides 150 mg/dL increased from 33% at baseline to 46% at the end of study (P 0.01). New-onset diabetes mellitus occurred in 13 patients (6%) with and in 4 patients (2%) without abdominal obesity. Baseline levels of glucose, triglyceride, and high-density lipoprotein predicted adverse outcomes, and predictors for new-onset diabetes mellitus after monotherapy in those with abdominal obesity included hydrochlorothiazide strategy (odds ratio: 46.91 [95% CI: 2.55 to 862.40]), female sex (odds ratio: 31.37 [95% CI: 2.10 to 468.99]), and uric acid (odds ratio: 3.19 [95% CI: 1.35 to 7.52]). Development of adverse metabolic effect, including new-onset diabetes mellitus associated with short-term exposure to hydrochlorothiazide and atenolol was more common in those with abdominal obesity. (Hypertension. 2010;55:61-68.)

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

A review of the effects of Capsicum annuum L. and its constituent, capsaicin, in metabolic syndrome

Objective(s): Metabolic syndrome, a coexisting of high blood glucose, obesity, dyslipidemia and hypertension, is an important risk factor for cardiovascular disease occurrence and mortality. Recently, there is a rising demand for herbal drugs which have less adverse effects and have shown more beneficial effects in comparison with synthetic options. Red pepper, with the scientific name of Capsi...

متن کامل

Impact of abdominal obesity on incidence of adverse metabolic effects associated with antihypertensive medications.

We assessed adverse metabolic effects of atenolol and hydrochlorothiazide among hypertensive patients with and without abdominal obesity using data from a randomized, open-label study of hypertensive patients without evidence of cardiovascular disease or diabetes mellitus. Intervention included randomization to 25 mg of hydrochlorothiazide or 100 mg of atenolol monotherapy followed by their com...

متن کامل

The Association between Macronutrient Intake and the Metabolic Syndrome in Yazdian Adult Population

Background: Metabolic syndrome (MetS) is a collection of metabolic disorders including abdominal obesity, dyslipidemia, high glucose levels, and high blood pressure. The macronutrients such as carbohydrates, proteins, and fats are the effective factors in the occurrence of MetS. This study aimed to determine the association between the macronutrients intake and MetS in 20-69 year-old adult popu...

متن کامل

Prevalence and Risk Factors of Diabetes, Pre-Diabetes and Metabolic Syndrome in First-Degree Relatives of Patients with Type II Diabetes

Background & Aims: The aim of this study was to estimate the prevalence and risk factors for diabetes, pre-diabetes and metabolic syndrome in first-degree relatives(FDRs) of patients with type 2 diabetes. Methods: In a cross-sectional study between 2003 and 2005, 3228 of first-degree relatives of patients with type 2 diabetes (841 men and 2387 women) from Isfahan Endocrine and Metabolism Resear...

متن کامل

فراوانی سندرم متابولیک در بیماران بستری در بخش قلب بیمارستان فرشچیان همدان

Background and Objective: The prevalence of metabolic syndrome is on a growing trend. Weight and age are among the most important factors affecting this condition. Evidence is indicative of a relationship between coronary heart diseases and metabolic syndrome. The present study was conducted to determine the prevalence of metabolic syndrome among patients admitted to the Cardiology Department o...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009